Search

Search results

92 results found

Protein Expression Profiles among Lichen Sclerosus Urethral Strictures-Can Urethroplasty Success be Predicted?

Publication: Journal Article

Levy, Alison C, Matthew Moynihan, Jennifer A Bennett, Travis Sullivan, Kristian Stensland, Brendan M Browne, Ariel Fredrick, et al. 2020. “Protein Expression Profiles Among Lichen Sclerosus Urethral Strictures-Can Urethroplasty Success Be Predicted?”. The Journal of Urology 203 (4): 773-78.

Epidermal growth factor receptor status and the response of bladder carcinoma cells to erlotinib.

Publication: Journal Article

Jacobs, Micah A, Chad Wotkowicz, Egbert D Baumgart, Brasil Silva Neto, Kimberly M Rieger-Christ, Trisha Bernier, Michael S Cohen, John A Libertino, and Ian C Summerhayes. 2007. “Epidermal Growth Factor Receptor Status and the Response of Bladder Carcinoma Cells to Erlotinib.”. The Journal of Urology 178 (4 Pt 1): 1510-4.

Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat.

Publication: Journal Article

Liu, Paul Y, Wenjing Tong, Kan Liu, Sang Hoon Han, Xiao Tian Wang, Evangelos Badiavas, Kimberly Rieger-Christ, and Ian Summerhayes. 2004. “Liposome-Mediated Transfer of Vascular Endothelial Growth Factor CDNA Augments Survival of Random-Pattern Skin Flaps in the Rat.”. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society 12 (1): 80-5.

The Role of MicroRNA in the Metastatic Phenotype of Bladder Cancer

Publication: Journal Article

Perecman, Aaron, Adam Wiggins, Jonathan T. Xu, Sanjna Das, Thomas Kalantzakos, Travis B Sullivan, and Kimberly M Rieger-Christ. 2022. “The Role of MicroRNA in the Metastatic Phenotype of Bladder Cancer”. Edited by Neil Barber and Ahmed Ali. Urologic Cancers.

Team

Page

Travis Sullivan

Person: Associate Director, Translational Research

Travis Sullivan is the Associate Director Of Translational Research at LHMC. He has thirteen years of experience in the Biotech industry developing biomarker assays, 10+ years of research efforts in Translational Research, two patents related to assay design, and over 30 publications in these fields...

New Publication to Cancers Special Issue Time for a Paradigm Shift in Non-muscle-invasive Bladder Cancer (Volume II)

News: May 11, 2024

Thanks to the efforts of all involved, we have just published a paper, "Treatment Modalities for Non-Muscle Invasive Bladder Cancer: An Updated Review" to Cancers Special Issue Time for a Paradigm Shift in Non-muscle-invasive Bladder Cancer (Volume II). Read Here

LuCNeSS Presentation at the 2024 Rescue Lung Rescue Life Conference

News: October 26, 2024

This year we were honored to have AJ Piper-Vallillo, MD present on LuCNeSS at the 2024 Rescue Lung Rescue Life Conference. This presentation highlighted our domestic LuCNeSS study and our World LuCNeSS study, as well was the study's preliminary results. Piper-Vallillo, AJ. Lung Cancer in those who...

Lung Health Foundation Presentation

News: February 11, 2025

On 11 February 2025, Dr. Carl Martin Tammemägi presented on the LuCNeSS study to the Lung Health Foundation. Tammemägi, Carl Martin. Identification of never smoking individuals at high risk for lung cancer. Presented to the Lung Health Foundation in Toronto, 11 February 2025. Toronto, Ontario...

Capacity assessment for EHR-based medical device post-market surveillance for synthetic mid-urethral slings among women with stress urinary incontinence: a NEST consortium study.

Publication: Journal Article

Matheny, Michael E, Amy M Perkins, Kimberly Rieger-Christ, Joseph S Ross, Jialin Mao, Art Sedrakyan, Nilay D Shah, et al. 2025. “Capacity Assessment for EHR-Based Medical Device Post-Market Surveillance for Synthetic Mid-Urethral Slings Among Women With Stress Urinary Incontinence: A NEST Consortium Study.”. BMJ Surgery, Interventions, & Health Technologies 7 (1): e000193.